-
PET Imaging Using 89Zr Labeled StarPEG Nanocarriers Reveals Heterogeneous Enhanced Permeability and Retention (EPR) in Prostate Cancer. Mol Cancer Ther. 2024 Sep 27.
Meher N, Bidkar AP, Wadhwa A, Bobba KN, Dhrona S, Dasari C, Mu C, Fong COY, Cámara JA, Ali U, Basak M, Bulkley D, Steri V, Fontaine SD, Zhu J, Oskowitz A, Aggarwal RR, Sriram R, Chou J, Wilson DM, Seo Y, Santi DV, Ashley GW, VanBrocklin HF, Flavell RR. PMID: 39331510.
View in:
PubMed Mentions: Fields:
-
3D small-scale dosimetry and tumor control of 225Ac radiopharmaceuticals for prostate cancer. Sci Rep. 2024 08 27; 14(1):19938.
Peter R, Bidkar AP, Bobba KN, Zerefa L, Dasari C, Meher N, Wadhwa A, Oskowitz A, Liu B, Miller BW, Vetter K, Flavell RR, Seo Y. PMID: 39198676; PMCID: PMC11358493.
View in:
PubMed Mentions: Fields:
Translation:
HumansAnimalsCells
-
A Technique to Quantify Very Low Activities in Regions of Interest With a Collimatorless Detector. IEEE Trans Med Imaging. 2024 Aug; 43(8):2745-2757.
Caravaca J, Bobba KN, Du S, Peter R, Gullberg GT, Bidkar AP, Flavell RR, Seo Y. PMID: 38478457; PMCID: PMC11293990.
View in:
PubMed Mentions:
1 Fields:
Translation:
Animals
-
Prostate-Specific Membrane Antigen Targeted StarPEG Nanocarrier for Imaging and Therapy of Prostate Cancer. Adv Healthc Mater. 2024 Jul; 13(19):e2304618.
Meher N, Ashley GW, Bobba KN, Wadhwa A, Bidkar AP, Dasari C, Mu C, Sankaranarayanan RA, Serrano JAC, Raveendran A, Bulkley DP, Aggarwal R, Greenland NY, Oskowitz A, Wilson DM, Seo Y, Santi DV, VanBrocklin HF, Flavell RR. PMID: 38700450; PMCID: PMC11281871.
View in:
PubMed Mentions: Fields:
Translation:
HumansAnimalsCells
-
Actinium-225 targeted alpha particle therapy for prostate cancer. Theranostics. 2024; 14(7):2969-2992.
Bidkar AP, Zerefa L, Yadav S, VanBrocklin HF, Flavell RR. PMID: 38773983; PMCID: PMC11103494.
View in:
PubMed Mentions:
1 Fields:
Translation:
HumansAnimals
-
CD46-Targeted Theranostics for PET and 225Ac-Radiopharmaceutical Therapy of Multiple Myeloma. Clin Cancer Res. 2024 03 01; 30(5):1009-1021.
Wadhwa A, Wang S, Patiño-Escobar B, Bidkar AP, Bobba KN, Chan E, Meher N, Bidlingmaier S, Su Y, Dhrona S, Geng H, Sarin V, VanBrocklin HF, Wilson DM, He J, Zhang L, Steri V, Wong SW, Martin TG, Seo Y, Liu B, Wiita AP, Flavell RR. PMID: 38109209; PMCID: PMC10905524.
View in:
PubMed Mentions:
5 Fields:
Translation:
HumansAnimalsCells
-
Development of CD46 targeted alpha theranostics in prostate cancer using 134Ce/225Ac-Macropa-PEG4-YS5. Theranostics. 2024; 14(4):1344-1360.
Bobba KN, Bidkar AP, Wadhwa A, Meher N, Drona S, Sorlin AM, Bidlingmaier S, Zhang L, Wilson DM, Chan E, Greenland NY, Aggarwal R, VanBrocklin HF, He J, Chou J, Seo Y, Liu B, Flavell RR. PMID: 38389832; PMCID: PMC10879874.
View in:
PubMed Mentions:
5 Fields:
Translation:
HumansAnimals
-
Highly efficient color-tunable organic co-crystals unveiling polymorphism, isomerism, delayed fluorescence for optical waveguides and cell-imaging. Nat Commun. 2023 Oct 20; 14(1):6648.
Barman D, Annadhasan M, Bidkar AP, Rajamalli P, Barman D, Ghosh SS, Chandrasekar R, Iyer PK. PMID: 37863932; PMCID: PMC10589249.
View in:
PubMed Mentions:
2 Fields:
-
Coded aperture and Compton imaging for the development of 225 Ac-based radiopharmaceuticals. Med Phys. 2023 Oct; 50(10):6454-6468.
Frame E, Bobba K, Gunter D, Mihailescu L, Bidkar A, Flavell R, Vetter K. PMID: 37672346.
View in:
PubMed Mentions:
4 Fields:
Translation:
Animals
-
Evaluation of 134Ce/134La as a PET Imaging Theranostic Pair for 225Ac α-Radiotherapeutics. J Nucl Med. 2023 07; 64(7):1076-1082.
Bobba KN, Bidkar AP, Meher N, Fong C, Wadhwa A, Dhrona S, Sorlin A, Bidlingmaier S, Shuere B, He J, Wilson DM, Liu B, Seo Y, VanBrocklin HF, Flavell RR. PMID: 37201957; PMCID: PMC10315697.
View in:
PubMed Mentions:
9 Fields:
Translation:
HumansAnimalsCells
-
Treatment of Prostate Cancer with CD46-targeted 225Ac Alpha Particle Radioimmunotherapy. Clin Cancer Res. 2023 05 15; 29(10):1916-1928.
Bidkar AP, Wang S, Bobba KN, Chan E, Bidlingmaier S, Egusa EA, Peter R, Ali U, Meher N, Wadhwa A, Dhrona S, Dasari C, Beckford-Vera D, Su Y, Tang R, Zhang L, He J, Wilson DM, Aggarwal R, VanBrocklin HF, Seo Y, Chou J, Liu B, Flavell RR. PMID: 36917693; PMCID: PMC10183825.
View in:
PubMed Mentions:
14 Fields:
Translation:
HumansAnimals
-
CD46 targeted 212Pb alpha particle radioimmunotherapy for prostate cancer treatment. J Exp Clin Cancer Res. 2023 Mar 11; 42(1):61.
Li J, Huang T, Hua J, Wang Q, Su Y, Chen P, Bidlingmaier S, Li A, Xie Z, Bidkar AP, Shen S, Shi W, Seo Y, Flavell RR, Gioeli D, Dreicer R, Li H, Liu B, He J. PMID: 36906664; PMCID: PMC10007843.
View in:
PubMed Mentions:
11 Fields:
Translation:
HumansAnimals
-
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer. Cancer Res. 2023 01 18; 83(2):301-315.
Chou J, Egusa EA, Wang S, Badura ML, Lee F, Bidkar AP, Zhu J, Shenoy T, Trepka K, Robinson TM, Steri V, Huang J, Wang Y, Small EJ, Chan E, Stohr BA, Ashworth A, Delafontaine B, Rottey S, Cooke KS, Hashemi Sadraei N, Yu B, Salvati M, Bailis JM, Feng FY, Flavell RR, Aggarwal R. PMID: 36351060; PMCID: PMC10263373.
View in:
PubMed Mentions:
16 Fields:
Translation:
HumansAnimals
-
Prostate-Specific Membrane Antigen Targeted Deep Tumor Penetration of Polymer Nanocarriers. ACS Appl Mater Interfaces. 2022 Nov 16; 14(45):50569-50582.
Meher N, Ashley GW, Bidkar AP, Dhrona S, Fong C, Fontaine SD, Beckford Vera DR, Wilson DM, Seo Y, Santi DV, VanBrocklin HF, Flavell RR. PMID: 36318757; PMCID: PMC9673064.
View in:
PubMed Mentions:
10 Fields:
Translation:
HumansCells
-
Synthesis and Preliminary Biological Assessment of Carborane-Loaded Theranostic Nanoparticles to Target Prostate-Specific Membrane Antigen. ACS Appl Mater Interfaces. 2021 Nov 24; 13(46):54739-54752.
Meher N, Seo K, Wang S, Bidkar AP, Fogarty M, Dhrona S, Huang X, Tang R, Blaha C, Evans MJ, Raleigh DR, Jun YW, VanBrocklin HF, Desai TA, Wilson DM, Ozawa T, Flavell RR. PMID: 34752058.
View in:
PubMed Mentions:
11 Fields:
Translation:
HumansAnimalsCells
-
Developing membrane-derived nanocarriers for ex vivo therapy of homologous breast cancer cells. Nanomedicine (Lond). 2021 09; 16(21):1843-1856.
Saha M, Bidkar AP, Ghosh SS. PMID: 34369819.
View in:
PubMed Mentions:
1 Fields:
Translation:
Cells
-
A conformational tweak for enhanced cellular internalization, photobleaching resistance and prolonged imaging efficacy. Chem Commun (Camb). 2020 Nov 26; 56(94):14861-14864.
Meher N, Bidkar AP, Barman D, Ghosh SS, Iyer PK. PMID: 33174881.
View in:
PubMed Mentions: Fields:
Translation:
HumansCells
-
Effect of Secondary Structure and Side Chain Length of Hydrophobic Amino Acid Residues on the Antimicrobial Activity and Toxicity of 14-Residue-Long de novo AMPs. ChemMedChem. 2021 01 19; 16(2):355-367.
Pandit G, Chowdhury N, Abdul Mohid S, Bidkar AP, Bhunia A, Chatterjee S. PMID: 33026188.
View in:
PubMed Mentions:
12 Fields:
Translation:
HumansAnimalsCells
-
Peptide Hydrogels as Platforms for Sustained Release of Antimicrobial and Antitumor Drugs and Proteins. ACS Appl Bio Mater. 2020 Sep 21; 3(9):6251-6262.
Roy K, Pandit G, Chetia M, Sarkar AK, Chowdhuri S, Bidkar AP, Chatterjee S. PMID: 35021757.
View in:
PubMed Mentions:
5 Fields:
-
Nerve growth factor from Indian Russell's viper venom (RVV-NGFa) shows high affinity binding to TrkA receptor expressed in breast cancer cells: Application of fluorescence labeled RVV-NGFa in the clinical diagnosis of breast cancer. Biochimie. 2020 Sep; 176:31-44.
Islam T, Majumder M, Bidkar A, Ghosh SS, Mukhopadhyay R, Utkin Y, Mukherjee AK. PMID: 32585227.
View in:
PubMed Mentions:
1 Fields:
Translation:
HumansAnimalsCells
-
Rationally designed antimicrobial peptides: Insight into the mechanism of eleven residue peptides against microbial infections. Biochim Biophys Acta Biomembr. 2020 04 01; 1862(4):183177.
Pandit G, Biswas K, Ghosh S, Debnath S, Bidkar AP, Satpati P, Bhunia A, Chatterjee S. PMID: 31954105.
View in:
PubMed Mentions:
12 Fields:
Translation:
HumansAnimalsCells
-
Red Blood Cell-Membrane-Coated Poly(Lactic-co-glycolic Acid) Nanoparticles for Enhanced Chemo- and Hypoxia-Activated Therapy. ACS Appl Bio Mater. 2019 Sep 16; 2(9):4077-4086.
Bidkar AP, Sanpui P, Ghosh SS. PMID: 35021341.
View in:
PubMed Mentions:
12 Fields:
-
Deciphering Hydrodynamic and Drug-Resistant Behaviors of Metastatic EMT Breast Cancer Cells Moving in a Constricted Microcapillary. J Clin Med. 2019 Aug 09; 8(8).
Nath B, Bidkar AP, Kumar V, Dalal A, Jolly MK, Ghosh SS, Biswas G. PMID: 31404980; PMCID: PMC6722803.
View in:
PubMed Mentions:
6
-
Combination Therapy with MAPK-Pathway-Specific Inhibitor and Folic-Acid-Receptor-Targeted Selenium Nanoparticles Induces Synergistic Antiproliferative Response in BRAF Mutant Cancer Cells. ACS Biomater Sci Eng. 2019 May 13; 5(5):2222-2234.
Bidkar AP, Sanpui P, Ghosh SS. PMID: 33405774.
View in:
PubMed Mentions:
3 Fields:
-
Insights into the Mechanism of Antimicrobial Activity of Seven-Residue Peptides. J Med Chem. 2018 09 13; 61(17):7614-7629.
Pandit G, Ilyas H, Ghosh S, Bidkar AP, Mohid SA, Bhunia A, Satpati P, Chatterjee S. PMID: 30070835.
View in:
PubMed Mentions:
4 Fields:
Translation:
HumansCells
-
Efficient induction of apoptosis in cancer cells by paclitaxel-loaded selenium nanoparticles. Nanomedicine (Lond). 2017 Nov; 12(21):2641-2651.
Bidkar AP, Sanpui P, Ghosh SS. PMID: 29043926.
View in:
PubMed Mentions:
14 Fields:
Translation:
HumansCells
-
Studying in vitro phagocytosis of apoptotic cancer cells by recombinant GMCSF-treated RAW 264.7 macrophages. Int J Biol Macromol. 2017 Sep; 102:1138-1145.
Selvarajan V, Bidkar AP, Shome R, Banerjee A, Chaubey N, Ghosh SS, Sanpui P. PMID: 28476594.
View in:
PubMed Mentions:
2 Fields:
Translation:
HumansAnimalsCells
-
Protein folding and misfolding in the neurodegenerative disorders: a review. Rev Neurol (Paris). 2014 Mar; 170(3):151-61.
Bolshette NB, Thakur KK, Bidkar AP, Trandafir C, Kumar P, Gogoi R. PMID: 24613386.
View in:
PubMed Mentions:
6 Fields:
Translation:
HumansCells